Parameters associated with improvement of systolic function in patients with heart failure

Liv Borum Schöps1,2,3, Morten Sengeløv4,2, Daniel Modin4,2

  • 1Department of Cardiology, Herlev and Gentofte Hospital, Hellerup, Denmark liv.schoeps@hotmail.com.

Insights

Most heart failure patients improved systolic function with treatment. Key echocardiographic measures and fewer comorbidities like diabetes predicted better left ventricular ejection fraction (LVEF) improvement and lower mortality risk.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Echocardiography

Background:

  • Heart failure with reduced ejection fraction (HFrEF) affects millions globally.
  • Improving systolic function is a key treatment goal in HFrEF.
  • Identifying predictors of systolic function improvement can optimize patient management.

Purpose of the Study:

  • To identify clinical and echocardiographic parameters associated with improved systolic function in HFrEF outpatients.
  • To explore the relationship between left ventricular ejection fraction (LVEF) improvement and mortality.

Main Methods:

  • Retrospective analysis of 686 HFrEF patients' echocardiograms from Gentofte Hospital.
  • Linear regression used to assess parameters linked to LVEF improvement.
  • Cox regression analyzed survival in relation to LVEF improvement.

Main Results:

  • 81.5% of patients showed improved systolic function (Δ LVEF >0%); 14.6% were super responders (Δ LVEF >20%).
  • LVEF improvement associated with better global longitudinal strain, higher tricuspid annular plane systolic excursion, smaller LV dimensions, lower E/A ratio, higher heart rate, and absence of ischemic cardiomyopathy and diabetes.
  • Higher LVEF improvement correlated with significantly lower mortality risk.

Conclusions:

  • The majority of HFrEF outpatients experienced improved systolic function with treatment.
  • Echocardiographic measures and comorbidities independently predicted LVEF improvement.
  • Greater LVEF improvement was significantly linked to reduced mortality.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
100